Saturday, March 15, 2025
1.3 C
London
HomeFinTechCreso Pharma: Posts 77pc revenue jump in Q3

Creso Pharma: Posts 77pc revenue jump in Q3

Date:

ABN AMRO-Owned Neobroker Fined $1.6M for Paying Finfluencers

A Significant Penalty in the Financial Industry Highlights Regulatory...

AvidXchange Explores Potential Sale Amid Market Changes

What Investors Need to Know About AvidXchange's Strategic ShiftHighlights:...

Raisin Expands Its Offerings by Launching in Finland

Discover how Raisin is transforming the financial landscape in...

Creso Pharma Posts 77pc revenue jump in Q3

  • Creso Pharma (CPH) reports a 77 per cent year-on-year (YoY) jump in group revenue to $2.05 million for the September quarter
  • This result takes Creso’s unaudited year-to-date revenue to roughly $6.4 million, which already exceeds 2021
  • The medicinal cannabis company says its subsidiaries “continued to perform pleasingly”, and it welcomed its initial revenue from recently-acquired Sierra Sage Herbs
  • Creso also signed a term sheet to acquire Health House International over the quarter, which reportedly generated $4.6 million in cash receipts during the quarter
  • Meanwhile, CPH has announced it’s raising up to $7.6 million through two separate convertible notes arrangements to support marketing and sales, Halucenex’s phase two clinical trial, and to review and complete any merger and acquisition opportunities
  • CPH shares are down 6.45 per cent to trade at 2.9 cents at 3:51 pm AEDT

Related stories

spot_img

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories